Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF
Status:
Recruiting
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare the effectiveness between early and late
initiation of anticoagulation therapy in acute ischemic stroke (AIS) patients with
non-valvular atrial fibrillation (NVAF). Participants will be 1:1 randomized into early or
late initiation group. The primary endpoint is early neurological deterioration (END) before
discharge.
Phase:
N/A
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University